We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+13.78%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$5.02B
AUM Growth
+$1.17B
Cap. Flow
+$816M
Cap. Flow %
16.26%
Top 10 Hldgs %
31.54%
Holding
2,471
New
743
Increased
409
Reduced
522
Closed
789

Sector Composition

Rank Sector Weight
1 Technology 10.94%
2 Financials 10.6%
3 Healthcare 8.31%
4 Industrials 7.75%
5 Consumer Discretionary 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
426
AbbVie
ABBV
$468B
$1.89M 0.04%
21,536
-7,192
-25% -$677K
DRNA
427
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$1.88M 0.04%
+104,335
New +$2.16M
BKI
428
DELISTED
Black Knight, Inc. Common Stock
BKI
$1.88M 0.04%
21,536
-137,912
-86% -$10.9M
CHTR icon
429
Charter Communications
CHTR
$17.9B
$1.87M 0.04%
2,992
-34,852
-92% -$20.6M
GOOG icon
430
Alphabet (Google) Class C
GOOG
$4.18T
$1.87M 0.04%
25,420
+10,180
+67% +$777K
TEAM icon
431
Atlassian
TEAM
$43.5B
$1.87M 0.04%
10,273
+6,109
+147% +$1.09M
SKY icon
432
Champion Homes
SKY
$4.9B
$1.86M 0.04%
69,534
+58,123
+509% +$1.58M
SAFM
433
DELISTED
Sanderson Farms Inc
SAFM
$1.86M 0.04%
15,740
-843
-5% -$98.5K
VRTX icon
434
Vertex Pharmaceuticals
VRTX
$139B
$1.86M 0.04%
6,822
-7,786
-53% -$2.15M
VSH icon
435
Vishay Intertechnology
VSH
$4.85B
$1.85M 0.04%
119,105
-75,133
-39% -$1.19M
MAXR
436
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$1.85M 0.04%
74,038
+27,433
+59% +$607K
ADBE icon
437
Adobe
ADBE
$109B
$1.84M 0.04%
+3,761
New +$1.75M
BIO icon
438
Bio-Rad Laboratories Class A
BIO
$10.2B
$1.83M 0.04%
3,560
-2,541
-42% -$1.29M
MNR
439
DELISTED
Monmouth Real Estate Investment Corp
MNR
$1.83M 0.04%
+132,333
New +$1.89M
WSBC icon
440
WesBanco
WSBC
$3.92B
$1.83M 0.04%
+85,568
New +$1.82M
CAH icon
441
Cardinal Health
CAH
$53.4B
$1.81M 0.04%
38,644
-26,913
-41% -$1.38M
NBIX icon
442
Neurocrine Biosciences
NBIX
$15.5B
$1.81M 0.04%
18,823
-7,353
-28% -$851K
FL
443
DELISTED
Foot Locker
FL
$1.8M 0.04%
+54,394
New +$1.66M
HIW icon
444
Highwoods Properties
HIW
$3.46B
$1.75M 0.04%
52,275
-27,961
-35% -$1.03M
DEI icon
445
Douglas Emmett
DEI
$1.97B
$1.75M 0.03%
69,781
+14,202
+26% +$400K
HPQ icon
446
HP
HPQ
$27.2B
$1.75M 0.03%
+92,255
New +$1.68M
HAE icon
447
CALL
Haemonetics
HAE
$4.95B
$1.75M 0.03%
+20,000
New +$1.75M
PRI icon
448
Primerica
PRI
$9.1B
$1.75M 0.03%
15,424
+8,851
+135% +$1.08M
UPLD icon
449
Upland Software
UPLD
$14.4M
$1.75M 0.03%
+4,627
New +$1.67M
WY icon
450
Weyerhaeuser
WY
$17.6B
$1.74M 0.03%
+61,150
New +$1.68M

Similar funds

Michael Gelband's Q3 2020 Portfolio in Review

As of Q3 2020, Michael Gelband held 2,471 positions worth $5.02B, up 30% from $3.85B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Michael Gelband deployed $816M of net new capital in Q3 2020, opening 743 new positions and adding to 409 existing holdings. Its largest new stake was State Street Energy Select Sector SPDR ETF: 1,291,886 shares worth $19.3M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $46.6M trimmed.

  • Michael Gelband's largest Q3 2020 buy was State Street Energy Select Sector SPDR ETF: 1,291,886 shares worth $19.3M.
  • Michael Gelband added most to Charles Schwab in Q3 2020, an estimated $64.4M increase.
  • Michael Gelband's biggest Q3 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $46.6M.
  • Michael Gelband fully exited State Street SPDR S&P 500 ETF Trust in Q3 2020, selling an estimated $88.3M.
  • Michael Gelband's ten largest holdings make up 32% of its $5.02B portfolio in Q3 2020.
  • Michael Gelband opened 743 new positions and closed 789 in Q3 2020.
  • Michael Gelband's portfolio value rose 30% quarter-over-quarter to $5.02B.

Based on ExodusPoint Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.